Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic iron oxide …
A Karakatsanis, S Eriksson, L Pistiolis… - Annals of Surgical …, 2023 - Springer
Background Difficulty in preoperatively assessing the risk for occult invasion or surgery that
precludes future accurate axillary mapping in patients with ductal cancer in situ (DCIS) …
precludes future accurate axillary mapping in patients with ductal cancer in situ (DCIS) …
Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal …
A Karakatsanis, AF Hersi, L Pistiolis… - Journal of British …, 2019 - academic.oup.com
Background One-fifth of patients with a preoperative diagnosis of ductal carcinoma in situ
(DCIS) have invasive breast cancer (IBC) on definitive histology. Sentinel lymph node …
(DCIS) have invasive breast cancer (IBC) on definitive histology. Sentinel lymph node …
Long-term outcome after retro-areolar versus peri-tumoral injection of superparamagnetic iron oxide nanoparticles (SPIO) for sentinel lymph node detection in breast …
F Wärnberg, E Stigberg, C Obondo, H Olofsson… - Annals of Surgical …, 2019 - Springer
Background/Objective SPIO is effective in sentinel node (SN) detection. No nuclear
medicine department is needed, and no allergic reactions have occurred. This study aimed …
medicine department is needed, and no allergic reactions have occurred. This study aimed …
Optimizing dose and timing in magnetic tracer techniques for sentinel lymph node detection in early breast cancers: the prospective multicenter SentiDose trial
AF Hersi, L Pistiolis, C Dussan Luberth, E Vikhe-Patil… - Cancers, 2021 - mdpi.com
Simple Summary Superparamagnetic iron oxide (SPIO) nanoparticles have comparable
performance to the combination of radioisotope and blue dye (RI+ BD) for sentinel lymph …
performance to the combination of radioisotope and blue dye (RI+ BD) for sentinel lymph …
Simplifying logistics and avoiding the unnecessary in patients with breast cancer undergoing sentinel node biopsy. A prospective feasibility trial of the preoperative …
A Karakatsanis, H Olofsson, P Stålberg… - … Journal of Surgery, 2018 - journals.sagepub.com
Purpose: Sentinel node is routinely localized with the intraoperative use of a radioactive
tracer, involving challenging logistics. Super paramagnetic iron oxide nanoparticle is a non …
tracer, involving challenging logistics. Super paramagnetic iron oxide nanoparticle is a non …
SentimagIC: a non-inferiority trial comparing superparamagnetic iron oxide versus technetium-99m and blue dye in the detection of axillary sentinel nodes in patients …
MD Alvarado, EA Mittendorf, M Teshome… - Annals of surgical …, 2019 - Springer
Background Sentinel lymph node biopsy (SLNB) is a highly accurate method for staging the
axilla in early breast cancer. Superparamagnetic iron oxide mapping agents have been …
axilla in early breast cancer. Superparamagnetic iron oxide mapping agents have been …
Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: a comparative non-inferiority study
A Piñero-Madrona, JA Torró-Richart… - European Journal of …, 2015 - Elsevier
Aims The gold standard for detection of Sentinel Lymph Nodes (SLN) is a combined
radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non …
radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non …
A novel method for intraoperative sentinel lymph node detection in prostate cancer patients using superparamagnetic iron oxide nanoparticles and a handheld …
A Winter, J Woenkhaus, F Wawroschek - Annals of surgical oncology, 2014 - Springer
Background A sentinel lymph node (SLN) biopsy using superparamagnetic iron oxide
nanoparticles (SPIOs) as a tracer instead of radioisotopes was first applied successfully in …
nanoparticles (SPIOs) as a tracer instead of radioisotopes was first applied successfully in …
Is sentinel lymph node dissection warranted for patients with a diagnosis of ductal carcinoma in situ?
AM Francis, CE Haugen, LM Grimes, JR Crow… - Annals of surgical …, 2015 - Springer
Background Positive sentinel lymph node (SLN) findings in ductal carcinoma in situ (DCIS)
range from 1 to 22% but have unknown biologic significance. This study sought to identify …
range from 1 to 22% but have unknown biologic significance. This study sought to identify …
Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: the French Sentimag feasibility trial
JL Houpeau, MP Chauvet, F Guillemin… - Journal of surgical …, 2016 - Wiley Online Library
Background and Objectives The French Sentimag feasibility trial evaluated a new method
for the localization of breast cancer sentinel lymph node (SLN) using Sienna+® …
for the localization of breast cancer sentinel lymph node (SLN) using Sienna+® …
相关搜索
- preoperative injection ductal cancer
- preoperative injection iron oxide
- iron oxide ductal cancer
- iron oxide sentinel nodes
- patients with a diagnosis ductal carcinoma
- breast cancer sentinel nodes
- iron oxide blue dye
- technetium 99m sentinel nodes
- blue dye sentinel nodes
- iron oxide technetium 99m
- preoperative diagnosis ductal cancer
- preoperative diagnosis iron oxide
- preoperative injection breast cancer
- preoperative injection ductal carcinoma
- iron oxide breast cancer